Pando Bioscience
Gen-AI Designed Enzymes for Pharmaceutical Innovation
Boston, United States · Founded 2022
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2022
- Website
- pando.bio
- Last Round
- SeedApr 2023
- Rounds
- 1
About
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.
Summary
Pando Bioscience is a Biotech company based in Boston, United States, founded in 2022. Its most recent funding was a Seed round in Apr 2023. Investors include Creative Destruction Lab, Y Combinator Continuity Fund and Endless Frontier Labs.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2023
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...